Search Results - Chao Xue
- Showing 1 - 4 results of 4
-
1
Dissecting the Cellular Heterogeneity Underlying Liver Diseases Through the Integration of GWASs and Single-Cell RNA Sequencing by Miao Zhou, Meng Liu, Chao Xue
Published 2025-06-01Liver diseases encompass a wide range of etiologies and involve highly heterogeneous cellular environments, yet the specific cellular states through which genetic risk contributes to disease remain incompletely understood. In this study, we integrated genome-wide association study (GWAS) data from s...
Get full text
Article -
2
The potential of olfaction loss to induce cognitive impairment and anxiety behavior in mice via the microbiota-gut-brain axis by Xiangyu Zhao, Chao Xue, Yiming Wang, Xiwei Liu, Ran Li, Xianfeng Yi
Published 2025-07-01IntroductionOlfactory dysfunction and cognition decline are frequently observed; however, very little is known about whether olfactory disorders trigger cognitive impairment.MethodsHere, we induced olfactory loss in mice and investigated whether and how olfactory loss induces cognitive impairment an...
Get full text
Article -
3
Super‐Heterostructures of Twisted Pd Nanoarrays Epitaxially Grown on Chiral Au Nanorods Boost Circularly Polarized Photocatalysis by Taotao Luo, Haoyu Li, Zhicheng Zhang, Shenli Wang, Xiaobin Pan, Stefanos Mourdikoudis, Chao Xue, Junjun Li, Kwok‐Yin Wong, Guangchao Zheng
Published 2025-07-01Abstract Seed‐mediated growth provides an efficient way to produce chiral hybrid nanocrystals, mainly benefitting from the recent successful synthesis of discrete chiral metal nanocrystals. However, the chiroptical response of chiral core‐shell nanostructures decreases rapidly when the functional la...
Get full text
Article -
4
Anticancer Quinolinol Small Molecules Target Multiple Pathways to Promote Cell Death and Eliminate Melanoma Cells Resistant to BRAF Inhibitors by Xinjiang Wang, Rati Lama, Alexis D. Kelleher, Erika C. Rizzo, Samuel L. Galster, Chao Xue, Yali Zhang, Jianmin Wang, Jun Qu, Sherry R. Chemler
Published 2025-06-01Small molecule inhibitors that target the E3 ligase activity of MDM2-MDM4 have been explored to inhibit the oncogenic activity of MDM2-MDM4 complex. MMRi62 is a small molecule that was identified using an MDM2-MDM4 E3 ligase-based high throughput screen and a cell-death-based secondary screen. Our p...
Get full text
Article